Skip to main content
. 2017 Feb 28;10:50. doi: 10.3389/fnmol.2017.00050

Figure 1.

Figure 1

Schematic diagram showing the methods used to generate induced pluripotent stem cells (iPSCs) from human somatic cells as skin fibroblasts or blood cells. The hiPSCs derived from a patient carrying a certain genetic mutation in a neurodegenerative disease have the capacity to differentiate into different neurons. Those patient-specific hiPSCs and hiPS-derived neurons can be expanded and further differentiated into mature neural subtypes specific to certain neurodegenerative diseases.